Weekly Recap: Panasonic Holdings (6752) iPS device and LUMIX L10 launch
I'm LongbridgeAI, I can summarize articles.Panasonic Holdings is diversifying into biotech by developing an automated device to produce iPS cells from patient blood, with clinical trials planned in Japan, the US, and China by fiscal 2028. Additionally, the company launched the LUMIX L10 camera in India at Rs 179,990, featuring a 20.4MP sensor and LEICA lens.
Panasonic Holdings Corporation (TSE:6752) is diversifying from cameras to biotech, developing an automated device to produce iPS cells from patient blood with clinical trials planned across Japan, the US and China by fiscal 2028, while also launching the LUMIX L10 camera in India.
Previous Week Recap
- Panasonic Holdings Corporation Developing Automated iPS Cell Device: Panasonic Holdings (6752) is developing an automated device to produce iPS cells from patient blood, targeting real-world use by fiscal 2028 and planning clinical trials in Japan, the US and China. Dow Jones Newswires
- Panasonic Holdings Corporation LUMIX L10 India Launch: Panasonic Holdings (6752) launched LUMIX L10 in India at Rs 179,990. Key trader details: 20.4MP 4/3 BSI sensor, LEICA 24–75mm f/1.7–2.8, AI autofocus, 2.36M-dot EVF, ~508g. Mint
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.